228 related articles for article (PubMed ID: 32660318)
1. Differential patterns of interhemispheric functional connectivity between AQP4-optic neuritis and MOG-optic neuritis: a resting-state functional MRI study.
Sun M; Zhou H; Xu Q; Yang M; Xu X; Zhou M; Wei S
Acta Radiol; 2021 Jun; 62(6):776-783. PubMed ID: 32660318
[TBL] [Abstract][Full Text] [Related]
2. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis.
Ramanathan S; Prelog K; Barnes EH; Tantsis EM; Reddel SW; Henderson AP; Vucic S; Gorman MP; Benson LA; Alper G; Riney CJ; Barnett M; Parratt JD; Hardy TA; Leventer RJ; Merheb V; Nosadini M; Fung VS; Brilot F; Dale RC
Mult Scler; 2016 Apr; 22(4):470-82. PubMed ID: 26163068
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.
Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ
JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571
[TBL] [Abstract][Full Text] [Related]
4. Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study.
Stiebel-Kalish H; Lotan I; Brody J; Chodick G; Bialer O; Marignier R; Bach M; Hellmann MA
PLoS One; 2017; 12(1):e0170847. PubMed ID: 28125740
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China.
Song H; Zhou H; Yang M; Tan S; Wang J; Xu Q; Liu H; Wei S
Br J Ophthalmol; 2019 Jun; 103(6):831-836. PubMed ID: 30049802
[TBL] [Abstract][Full Text] [Related]
6. Comparison of spontaneous brain activity revealed by regional homogeneity in AQP4-IgG neuromyelitis optica-optic neuritis versus MOG-IgG optic neuritis patients: a resting-state functional MRI study.
Wang J; Tian Y; Shao Y; Feng H; Qin L; Xu W; Liu H; Xu Q; Wei S; Ma L
Neuropsychiatr Dis Treat; 2017; 13():2669-2679. PubMed ID: 29123400
[TBL] [Abstract][Full Text] [Related]
7. Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.
Havla J; Kümpfel T; Schinner R; Spadaro M; Schuh E; Meinl E; Hohlfeld R; Outteryck O
J Neurol; 2017 Jan; 264(1):139-151. PubMed ID: 27844165
[TBL] [Abstract][Full Text] [Related]
8. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.
Chen JJ; Bhatti MT
Curr Opin Neurol; 2020 Feb; 33(1):47-54. PubMed ID: 31743235
[TBL] [Abstract][Full Text] [Related]
9. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies.
Hassan MB; Stern C; Flanagan EP; Pittock SJ; Kunchok A; Foster RC; Jitprapaikulsan J; Hodge DO; Bhatti MT; Chen JJ
Am J Ophthalmol; 2020 Dec; 220():110-114. PubMed ID: 32707199
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis.
Martinez-Hernandez E; Sepulveda M; Rostásy K; Höftberger R; Graus F; Harvey RJ; Saiz A; Dalmau J
JAMA Neurol; 2015 Feb; 72(2):187-93. PubMed ID: 25506781
[TBL] [Abstract][Full Text] [Related]
11. The prevalence and prognostic value of myelin oligodendrocyte glycoprotein antibody in adult optic neuritis.
Liu H; Zhou H; Wang J; Sun M; Teng D; Song H; Xu Q; Wei S
J Neurol Sci; 2019 Jan; 396():225-231. PubMed ID: 30522039
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients.
Zhao Y; Tan S; Chan TCY; Xu Q; Zhao J; Teng D; Fu H; Wei S
Br J Ophthalmol; 2018 Oct; 102(10):1372-1377. PubMed ID: 29363529
[TBL] [Abstract][Full Text] [Related]
13. Acute idiopathic optic neuritis: not always benign.
Deschamps R; Gueguen A; Lecler A; Lecouturier K; Lamirel C; Bensa C; Marignier R; Vignal C; Gout O
Eur J Neurol; 2018 Nov; 25(11):1378-1383. PubMed ID: 30004610
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China.
Zhao G; Chen Q; Huang Y; Li Z; Sun X; Lu P; Yan S; Wang M; Tian G
J Neurol; 2018 Jan; 265(1):33-40. PubMed ID: 29101456
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the retinal vascular network and structure in patients with optic neuritis associated with myelin oligodendrocyte glycoprotein or aquaporin-4 antibodies: an optical coherence tomography angiography study.
Yu J; Huang Y; Zhou L; ZhangBao J; Zong Y; Quan C; Wang M
J Neurol; 2021 Dec; 268(12):4874-4881. PubMed ID: 34086096
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic and Clinical Characteristics of Optic Neuritis in Japan.
Ishikawa H; Kezuka T; Shikishima K; Yamagami A; Hiraoka M; Chuman H; Nakamura M; Hoshi K; Goseki T; Mashimo K; Mimura O; Yoshitomi T; Tanaka K;
Ophthalmology; 2019 Oct; 126(10):1385-1398. PubMed ID: 31196727
[TBL] [Abstract][Full Text] [Related]
17. A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection.
Nakamura M; Iwasaki Y; Takahashi T; Kaneko K; Nakashima I; Kunieda T; Kaneko S; Kusaka H
Mult Scler Relat Disord; 2017 Oct; 17():148-150. PubMed ID: 29055448
[TBL] [Abstract][Full Text] [Related]
18. Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients.
Deschamps R; Lecler A; Lamirel C; Aboab J; Gueguen A; Bensa C; Vignal C; Gout O
Eur J Neurol; 2017 Jun; 24(6):875-879. PubMed ID: 28477397
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of anti-myelin oligodendrocyte glycoprotein antibody positive optic neuritis.
Kezuka T; Ishikawa H
Jpn J Ophthalmol; 2018 Mar; 62(2):101-108. PubMed ID: 29445944
[TBL] [Abstract][Full Text] [Related]
20. The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients.
Siritho S; Sato DK; Kaneko K; Fujihara K; Prayoonwiwat N
Mult Scler; 2016 Jun; 22(7):964-8. PubMed ID: 26498263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
